SUNRISE Tx EIisa –a connected, affordable light solution for treating sleep apnea.
- Coordinator
- Sunrise, Belgium
- Runs
- 1 July 2022 to 31 December 2024
- Status
- Finished
- EU funding
- €1.9m
- Total cost
- €2.8m
- Partners
- 1 organisations in 1 countries
- Type
- European Innovation Council
- Grant agreement
- 190180051
What the project is doing
In the project's own words, from its summary on CORDIS.
Sunrise is a leading researcher and developer of solutions for diagnosis and treatment of sleep apnea. Our goal is to develop and commercialise Sunrise Tx, the first truly non-invasive, affordable and readily accessible solution to treat sleep apnea. This is to address the 80% treatment gap of sleep apnea sufferers who fail to access treatment due to high costs and long waiting times for diagnosis. Also, even within those diagnosed, at least 35% fail to comply with wearing a mask all night strapped tightly to the face, blowing air to clear airways for breathing due to the associated discomfort.
In contrast Sunrise Tx is a wearable device involving no nasal obstruction. Sunrise Tx is set to improve treatment access, compliance, cost and accuracy.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Sunrise | Namur | Belgium | Coordinator |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI